Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population

NCT05724446 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Cataracts Infantile

Interventions

DRUG: Clobetasol Propionate
DRUG: Prednisolone acetate ophthalmic suspension, 1%

Sponsor

Salvat